ViewsML Technologies Inc. (ViewsML), a techbio company revolutionizing spatial biology, has completed its seed financing round.
ViewsML's technology virtualizes IHC to predict biomarker expression both spatially and quantitatively at the cellular level, revolutionizing traditional methods.
Fasken advised ViewsML with a team led by Brock Euper (Corporate Commercial) and included Geoff Pedlow (M&A).
Jurisdiction
- British Columbia
